Establishing the diagnosis of Libman-Sacks endocarditis in systemic lupus erythematosus

Journal of General Internal Medicine

Volumn 23, Issue 6, 2008, Pages 883-886

  Ménard, Geraldine E ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Blood cultures; Echocardiogram; Libman Sacks endocarditis; Systemic lupus erythematosus

Indexed keywords

AMLODIPINE; ATORVASTATIN; CALCITRIOL; CARVEDILOL; DIPYRIDAMOLE; ERYTHROPOIETIN; GENTAMICIN; HYDROXYCHLOROQUINE; LOSARTAN; OMEPRAZOLE; PHENYTOIN; PREDNISONE; VANCOMYCIN;

ADULT; ANAMNESIS; AORTIC VALVE REPAIR; ARTICLE; BACTERIAL ENDOCARDITIS; BLOOD CELL COUNT; BLOOD CULTURE; CASE REPORT; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DRUG MEGADOSE; DYSPNEA; ENDOCARDITIS; FEMALE; FEVER; HOSPITAL ADMISSION; HUMAN; INFECTION PREVENTION; LABORATORY TEST; LIBMAN SACKS ENDOCARDITIS; NEUROLOGIC EXAMINATION; PHYSICAL EXAMINATION; SYSTEMIC LUPUS ERYTHEMATOSUS; THORAX RADIOGRAPHY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTICOAGULANTS; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; ENDOCARDITIS; FEMALE; FEVER; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MITRAL VALVE; PREDNISONE;

EID: 43949126164     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-008-0627-8     Document Type: Article

References (16)

1. Libman E, Sacks B. A hitherto undescribed form of valvular and mural endocarditis. Arch Intern Med. 1924;33:701-7.
2. Hojnik M, et al. Heart involvement (Libman Sacks endocarditis) in the antiphospholipid syndrome. Circulation. 1996;93:1579-87.
3. Chartash EK, et al. Aortic insufficiency and mitral regurgitation in patients with systemic lupus erythematosus and the antiphospholipid syndrome. Am J Med. 1989;86:407-12.
4. Moyssakis I, et al. Libman-Sacks endocarditis in systemic lupus erythematosus: prevalence, associations, and evolution. Am J Med. 2007;120:636-42.
5. Roldan CA, Shively BK, Lau CC, et al. Systemic lupus erythematosus valve disease by transesophageal echocardiography and the role of antiphospholipds antibodies. J Am Coll Cardiol. 1992;20:1127-34.
6. Roldan CA, Shivley BK, Crawford MH. An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus. N Engl J Med. 1996;335:1424-30.
7. Farzaneh-far A, Roman MJ, Lockshin MD, et al. Relationship of antiphospholipid antibodies to cardiovascular manifestations of systemic lupus erythematosus. Arthritis Rheum. 2006;54:3918-25.
8. Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30:633.
9. Asherson R, Cervera R. Antiphospholipid Antibodies and the Heart. Circulation. 1991;84(2):920-22.
10. Barnes EV, Narain S, Naranjo A, et al. High sensitivity C-reactive protein in systemic lupus erythematosus: relation to disease activity, clinical presentation and implications for cardiovascular risk. Lupus. 2005;14:576-82.
11. Leszcerynski P, et al. Cardiac valvular disease in patients with systemic lupus erythematosus. Relationship with anticardiolipin antibodies. Clin Rheumatol. 2003;22(6):405-8.
12. Amoroso A, Cacciapaglia F, De Castro S, et al. The adjunctive role of antiphopholpid antibodies in systemic lupus erythematosus cardiac involvement. Clin Exp Rheumatol. 2006;24(3):286-94.
13. Perez-Villa F, et al. Severe valvular regurgitation and antiphospholipid antibodies in systemic lupus erythematosus: a prospective, long-term follow up study. Arthritis Rheum. 2005;53(3):460-67.
14. Paran D, Caspi D, Levartovsky D, et al. Cardiac dysfunction in patients with systemic lupus erythematosus and antiphospholipid syndrome. Ann Rheum Dis. 2007;66:506-10.
15. Roland CA. Valvular disease associated with systemic illness. Cardiol Clin. 1998;16(3):531-50.
16. Gonzales-Juanatey C. Libman Sacks endocarditis and primary antiphospholipid syndrome. J Heart Valve Dis. 2005;14:700-2.